explore -WSS

explore

author：Wikipedia 2025-10-02 06:15:55 - browse：3

Adam's take main illustration — Molly Ferguson/STAT

The approval Friday of Bluebird Bio’s gene therapy for sickle cell disease should have been a momentum-swinging achievement for the long-struggling biotech. Instead, the company mispriced its new drug and fumbled a pivotal financial lifeline.

The consequences of these strategic blunders — arguably, self-inflicted — could imperil Bluebird’s independence, perhaps even its survival.

Bluebird priced Lyfgenia at $3.1 million, while Vertex Pharmaceutical set the cost of Casgevy, its competing sickle cell treatment also approved on Friday, at $2.2 million. Not only is Lyfgenia significantly more expensive, but its prescribing label carries a “black box” safety warning, which requires patients undergo regular blood monitoring for cancer risk. Casgevy has no similar monitoring requirement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Oral obesity drug from Viking Therapeutics hits key early target

WSS

Four alarming medical procedures we’re glad history forgot

Trial using CRISPR to edit HIV out of cells disappoints

Multiple sclerosis has subtypes with different best treatments: study

Bird flu in dairy cattle: New measures to control spread to humans

Bird flu reported in person exposed to presumably infected cattle

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

knowledge

explore

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Oral obesity drug from Viking Therapeutics hits key early target

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Researchers test human milk's ability to repair gut microbiome

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Oral obesity drug from Viking Therapeutics hits key early target

Guidelines to prevent youth baseball injuries need more muscle

Gut bacteria may contribute to kidney autoimmunity, study finds

Tori Bowie and the unacceptable rates of Black maternal death

Gut bacteria may contribute to kidney autoimmunity, study finds

knowledge

Florida Supreme Court upholds state's abortion ban

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Florida Supreme Court upholds state's abortion ban

Trial using CRISPR to edit HIV out of cells disappoints

Researchers test human milk's ability to repair gut microbiome

Pancreatic cancer is often deadly, but new discoveries are raising hope

explore

focus

focus

knowledge